Australia - English - Department of Health (Therapeutic Goods Administration)

bridge healthcare pty ltd - oyster shell,zinc oxide -

Ireland - English - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals (ireland) ltd - phenytoin sodium - solution for injection - 250 mg/5ml - hydantoin derivatives

Australia - English - Department of Health (Therapeutic Goods Administration)

sysmex australia pty ltd - ct929 - acquired genetic alteration ivds - ivds that are intended to be used in genetic testing to provide information about acquired genetic alterations, which may include chromosomal alterations, mutations and/or alterations in gene expression, and which may be used to characterise haematological or solid tumour malignancies and/or provide prognostic information. these products are intended for use as an adjunct to classic cytogenetics and not as independent tests or assays.

Australia - English - Department of Health (Therapeutic Goods Administration)

agentmolar pty ltd - 31783 - crown/bridge, temporary, polymer based - this thermoplastic material is used in the dental profession. the thermoplastic material becomes malleable when heat is applied (eg. immersing in hot water) and can adapt readily to the desired shape and after cooling, have sufficient rigidity to give detailed morphology. this material offers a simplified method for making the rigid implant stent in a process that can take as little as 10 minutes. the easy-to-use material offers the necessary rigidity, but it can be readily trimmed and requires minimal effort to remove. it can also is be used to make temporary crowns, mouth guards, as well as assist in bite registration materials amongst other applications.

Australia - English - Department of Health (Therapeutic Goods Administration)

dio australia pty ltd - 38781 - crown/bridge material, polymer based - this device is a material of photopolymer for manufacturing of 3d printed temporary dental crown and bridge to be used for less than 30 days. it can be used as a preformed denture tooth used for long-term denture (more than 30 days). this device for 3d printers is a light-curable polymerizable resin to fabricate, by additive manufacturing, denture tooth to be used in a denture or crown and bridge. the fabrication of temporary crowns, bridges and denture tooth with this device requires digital models, a stereolithographic additive printer, and curing light equipment.

Australia - English - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - desmopressin acetate -

Australia - English - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - somatropin -

Australia - English - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - desmopressin, quantity: 240 microgram (equivalent: desmopressin acetate, qty 272 microgram) - wafer - excipient ingredients: mannitol; citric acid; gelatin - 1- cranial diabetes insipidus. 2- primary nocturnal enuresis in patients from 6 years of age with normal ability to concentrate urine who are refractory to an enuresis alarm or in whom the enuresis alarm is contraindicated or inappropriate.

Australia - English - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - desmopressin, quantity: 120 microgram (equivalent: desmopressin acetate, qty 136 microgram) - wafer - excipient ingredients: citric acid; mannitol; gelatin - 1- cranial diabetes insipidus. 2- primary nocturnal enuresis in patients from 6 years of age with normal ability to concentrate urine who are refractory to an enuresis alarm or in whom the enuresis alarm is contraindicated or inappropriate.

Australia - English - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - progesterone, quantity: 100 mg - pessary, compressed - excipient ingredients: lactose monohydrate; pregelatinised maize starch; magnesium stearate; povidone; adipic acid; sodium lauryl sulfate; colloidal anhydrous silica; sodium bicarbonate - endometrin pessaries are indicated for luteal support as part of an assisted reproductive technology (art) treatment programme for infertile women.